Andreas Charalambous, ECO Summit 2021: Challenges to Cancer Care in Europe
We were delighted to catch up with Dr Andreas Charalambous, President-Elect of the European Cancer Organisation, to discuss the main challenges to cancer care in Europe in the next 5 years.
Speaker Disclosure: Andreas Charalambous has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the European Cancer Summit 2021
Share this Video
Related Videos In Policy
Helena Ullgren: PrEvCan | Focus on alcohol and cancer prevention
The European Code Against Cancer (ECAC) recommends that if you drink alcohol of any type you should limit your intake and that not drinking alcohol is best for cancer prevention. This March, the PrEvCan campaign, spearheaded by EONS to promote cancer prevention across Europe, is bringing attention to the link between alcohol consumption and cancer […]
Pompiliu Piso: ESSO Oncopolicy – cross-multidisciplinary training in oncology at the EU level (Part 2)
The European Society of Surgical Oncology (ESSO), along with other cancer-related European societies, supported the proposal for cross-multidisciplinary training in oncology at the EU level. It was a pleasure to talk with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, Regensburg, Germany) to discuss how cross-multidisciplinary training would affect cancer care in Europe and the other initiatives […]
Pompiliu Piso: ESSO’s open letter recognizing surgical oncology as a specialist discipline in the EU (Part 1)
The European Society of Surgical Oncology (ESSO) recently released an open letter urging the European Commission to recognise surgical oncology as a specialist discipline in the EU, entitled ‘Time to act: Maximizing the benefits of surgical oncology for cancer patients in Europe‘. touchONCOLOGY were delighted to catch up with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!